BioVaxys Technology Corp. Closes Debt Settlement Transaction
Thenewswire·2025-11-25 22:15
VANCOUVER, BC, November 25, 2025 – TheNewswire - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company”) announces that, further to its news release dated November 14, 2025, it has issued 1,792,387 common shares in the capital of the Company (each a “Settlement Share”), at a deemed value of $0.23 per Settlement Share, in full and final settlement of accrued and outstanding indebtedness in the aggregate amount of $412,249 (the “Debt Settlement Transaction”). All securities issued in ...